1. Home
  2. EEIQ vs XRTX Comparison

EEIQ vs XRTX Comparison

Compare EEIQ & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EpicQuest Education Group International Limited

EEIQ

EpicQuest Education Group International Limited

N/A

Current Price

$2.80

Market Cap

3.8M

Sector

Real Estate

ML Signal

N/A

Logo XORTX Therapeutics Inc.

XRTX

XORTX Therapeutics Inc.

N/A

Current Price

$2.25

Market Cap

4.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EEIQ
XRTX
Founded
2017
2011
Country
United States
Canada
Employees
N/A
3
Industry
Other Consumer Services
Pharmaceuticals and Biotechnology
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
4.2M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
EEIQ
XRTX
Price
$2.80
$2.25
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.3K
8.5K
Earning Date
01-28-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$0.35
52 Week High
$12.70
$3.60

Technical Indicators

Market Signals
Indicator
EEIQ
XRTX
Relative Strength Index (RSI) 57.16 48.71
Support Level $2.45 $1.99
Resistance Level $2.91 $2.29
Average True Range (ATR) 0.19 0.17
MACD 0.03 0.02
Stochastic Oscillator 70.30 33.33

Price Performance

Historical Comparison
EEIQ
XRTX

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S, Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. The Company's revenue is derived from foreign education programs, university education programs and student accommodation services.

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.

Share on Social Networks: